RheADC (Private limited company)
RheADC is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1014.500.036. It was founded on 02-10-2024. Its registered office is in Leuven. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € -114 379 and a loss of € 124 379. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk).
Information last updated on 07-10-2026.
Company information
Key figures of RheADC
| 2025 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -124 379 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -114 379 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 31 395 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -116 226 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| SOUND & SILENCE | 3001 Leuven |
| Formac Pharmaceuticals | 3001 Leuven |
| FOCUS PHARMA | 3001 Leuven |
| Perseus Biomics | 3001 Leuven |
| Raya Therapeutic | 3001 Leuven |
| COULTREON BIOPHARMA | 3001 Leuven |
| Open Alzheimer | 3001 Leuven |
| Lever Bio Belgium | 3001 Leuven |
Frequently asked questions
Is RheADC still active? Yes. The Crossroads Bank for Enterprises lists RheADC as active.
What is the VAT number of RheADC? The VAT number of RheADC is BE 1014.500.036.
When was RheADC founded? RheADC was founded on 02-10-2024.
What is the address of RheADC? The current registered office of RheADC is Ambachtenlaan 1, 3001 Louvain.
When did RheADC last file annual accounts? The latest annual accounts of RheADC were filed on 11-06-2026.
Is RheADC financially healthy? Addrly gives RheADC a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is RheADC profitable? The annual accounts of RheADC for 2025 show a loss of € 124 379.
What is the equity of RheADC? The equity of RheADC was € -114 379 at the close of the 2025 financial year.
Who are the directors of RheADC? The annual accounts of RheADC record 2 mandates. The names, roles and dates are visible with a free account.
Can RheADC receive Peppol e-invoices? Yes. RheADC is registered on the Peppol network and can receive structured electronic invoices.
What does RheADC do? The main activity of RheADC is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.